论文部分内容阅读
2014年3月29日,“CREATE-默克雪兰诺中国生殖医学研究基金(Merck Serono China Research Fund for Fertility Experts,CREATE)”项目在2014全面质量管理高峰论坛(西安)正式宣布启动。此基金旨在鼓励中国优秀中、青年学者开展针对生殖医学的临床研究(Clinical Research)及转化型医学研究(Translational Research),促进对不孕症治疗的深入研究,增进生殖医学专业工作者之间的研究合作与学术交流,改善辅助生殖治疗的结局,并最终提高活产率。基金规模计划每年出资400万元人民币,申请截止日期2014年6月30日,相关评审工作将保证公平、公正、公开原则,同时采纳乔杰教授的倡议:基金委的专家积极参与评审,坚持公平、公正原则,确保CREATE基金可以成为生殖领域让中青
On March 29, 2014, the “CREATE-CRECR” project was officially announced at the 2014 Total Quality Management Summit (Xi’an). The purpose of this fund is to encourage Chinese excellent young and middle-aged scholars to conduct clinical research and translational research on reproductive medicine so as to promote in-depth study on the treatment of infertility and promote cooperation between reproductive medicine professionals Research collaboration and academic exchange to improve the outcomes of assisted reproductive therapy and ultimately increase live birth rates. The fund scale plans to invest 4 million yuan each year, the deadline for application June 30, 2014, the relevant assessment will ensure the principle of fairness, fairness and openness. At the same time, it adopts the advice of Professor Qiao Jie: Experts from the Fund Committee actively participate in the assessment and uphold fairness , The principle of fairness, to ensure that the CREATE Fund can become a fertile field for young people